Selected article for: "acute phase and clinical decision"
Author: Ng, Pak C.; Lam, Hugh S.
Title: Biomarkers for Late-Onset Neonatal Sepsis: Cytokines and Beyond
  • Cord-id: g6ype3ck
  • Document date: 2010_8_31
    • ID: g6ype3ck
    Snippet: Acute phase reactants, pro and antiinflammatory mediators including chemokines and cytokines, and cell-surface antigens are nonspecific biomarkers that have been extensively studied for the diagnosis and management of late-onset neonatal sepsis (LONS) and necrotizing enterocolitis. It is expected that the next generation of biomarkers and tests will be more specific, will pinpoint the precise disease entity, and will provide crucial information on the exact pathogen or category of microorganism
    Document: Acute phase reactants, pro and antiinflammatory mediators including chemokines and cytokines, and cell-surface antigens are nonspecific biomarkers that have been extensively studied for the diagnosis and management of late-onset neonatal sepsis (LONS) and necrotizing enterocolitis. It is expected that the next generation of biomarkers and tests will be more specific, will pinpoint the precise disease entity, and will provide crucial information on the exact pathogen or category of microorganism and its antibiotic profile within hours of clinical presentation. Research on molecular pathogen detection and proteomic profiling has shown promising results. Academic-industry partnerships are vital for successful development of new diagnostic biomarkers for LONS, which are sensitive, inexpensive, fully automated, and easy to measure, allowing a quick turnaround time for clinical decision making.

    Search related documents:
    Co phrase search for related documents
    • abdominal sepsis and acute respiratory syndrome: 1, 2, 3, 4, 5
    • academic industry and acute phase: 1
    • academic industry and acute respiratory syndrome: 1, 2, 3, 4
    • accurate early and acute management: 1, 2
    • accurate early and acute phase: 1, 2
    • accurate early and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • accurate early identification and acute phase: 1
    • accurate early identification and acute respiratory syndrome: 1, 2
    • activation regulate and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7
    • active compound and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20